REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 26th, 2016 • Medpace Holdings, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledJuly 26th, 2016 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of [●], 2016 by and among Medpace Holdings, Inc., a Delaware corporation (the “Company”), Fifth Cinven Fund (No. 1) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 2) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 3) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 4) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 5) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund (No. 6) Limited Partnership, a Guernsey limited partnership, Fifth Cinven Fund Co-Investment Partnership, a general partnership formed under the laws of England and Wales, and Fifth Cinven Fund FCP-SIF, a Luxembourg fond commun de placement (collectively, “Cinven”), and Dr. August J. Troendle (“Dr. Troendle”) as of the date hereof.
VOTING AGREEMENTVoting Agreement • July 26th, 2016 • Medpace Holdings, Inc. • Services-commercial physical & biological research • Delaware
Contract Type FiledJuly 26th, 2016 Company Industry JurisdictionTHIS VOTING AGREEMENT, dated as of [●], 2016, is entered into by and between (i) Dr. August J. Troendle (“Dr. Troendle”) and (ii) the entities listed on Schedule 1 attached hereto (collectively, the “Cinven Stockholders” and, together with Dr. Troendle, the “Principal Stockholders”). Capitalized terms used herein without definition shall have the meanings set forth in Section 1.1.
Amended and Restated Employment AgreementEmployment Agreement • July 26th, 2016 • Medpace Holdings, Inc. • Services-commercial physical & biological research • Ohio
Contract Type FiledJuly 26th, 2016 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”), entered into on July 25, 2016 (the “Effective Date”), is made by and between Dr. August J. Troendle (the “Executive”) and Medpace Holdings Inc., a Delaware corporation (together with any of its subsidiaries and Affiliates (as defined below) as may employ the Executive from time to time (including Medpace Inc.), and any successor(s) thereto, the “Company”).